Mr Wenzhen Dai > Haiwen & Partners > Beijing, China > Lawyer Profile

Haiwen & Partners
20/F FORTUNE FINANCIAL CENTER
5 DONG SAN HUAN CENTRAL ROAD
CHAOYANG DISTRICT
100020
China
Wenzhen Dai photo

Work Department

Capital Markets, Mergers & Acquisitions, Private Equity

Position

Partner

Career

Mr. Dai is a partner of Haiwen.  Mr. Dai has over 20 years of legal experiences, and has widely been regarded by the clients and industry as expert in his practicing areas.  Mr. Dai’s practice focuses on capital markets, mergers and acquisitions, and general corporate matters.  Mr. Dai joined Haiwen in 2002.  Mr. Dai worked at Slaughter and May in its Hong Kong office and London office from 2007 to 2008.  Mr. Dai rejoined Haiwen in 2009.

Languages

Mr. DAI's native language is Mandarin, and he speaks English fluently.

Education

Mr. DAI received his LL.B. degree and his Master of Laws degree from Peking University in 1999 and 2002, respectively, and his LL.M. degree from University of Pennsylvania Law School in 2007.

Lawyer Rankings

China > Tax: PRC firms

Fielding several members with experience of working at international accounting firms, Haiwen & Partners‘ tax practice covers general tax advisory matters, due diligence, audit support, and tax dispute resolution. The team is also active in tax structuring, and the tax aspects of major transactions. Yongmao Guo‘s experience includes assisting several Chinese businesses with their outbound investments; and his sector expertise covers several industries, including finance, real estate, energy, and investment funds. M&A specialist Wenzhen Dai provides additional partner-level support; and the tax consulting practice of counsel Li Yang covers general corporate matters, M&A, restructuring, asset and equity-related transactions, and tax dispute resolution.

China > Life sciences and healthcare: PRC firms

Haiwen & Partners acts for both PRC biotech companies and large foreign financial services investors, assisting with financing work in the healthcare and life sciences space. Practice head Tina Wu is also highly experienced in clinical research, product development and regulatory compliance matters. Key names on the transactional and investment funds side include Hao Bian and Wenzhen Dai.